Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
The destruction of beta cells in type 1 diabetes (T1D) results in loss of insulin production and glucose homeostasis. Treatment of non-obese diabetic (NOD) mice with immune-depleting/modulating agents (e.g., anti-CD3, murine anti-thymocyte-globulin (mATG)) can lead to diabetes reversal. However, for...
Main Authors: | Nicola Gagliani, Tatiana Jofra, Amanda L Posgai, Mark A Atkinson, Manuela Battaglia |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4651367?pdf=render |
Similar Items
-
Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation.
by: Nicola Gagliani, et al.
Published: (2011-01-01) -
Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection
by: Shusen Wang, et al.
Published: (2015-06-01) -
Induction of Allogeneic Islet Tolerance in a Large-Animal Model
by: Peter J. Horton, et al.
Published: (2000-11-01) -
Combination of an Antigen-Specific Therapy and an Immunomodulatory Treatment to Simultaneous Block Recurrent Autoimmunity and Alloreactivity in Non-Obese Diabetic Mice.
by: Georgia Fousteri, et al.
Published: (2015-01-01) -
NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters - Reply
by: Mayor, N, et al.
Published: (2008)